VISEN Pharmaceuticals
$2.10
0
+$0.00+0%Friday 17:11
Statistics
Day High
2.1
Day Low
2.1
52W High
2.1
52W Low
2.1
Volume
100
Avg. Volume
-
Mkt Cap
239.25M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Aug 27Expected
Q2 2025
Q4 2025
Q2 2026
-0.16
-0.16
-0.15
-0.14
Expected EPS
N/A
Actual EPS
-0.139821
Financials
-151,916.63%Profit Margin
Unprofitable23,584.57Revenue
-35.83MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
VISEN Pharmaceuticals operates as an investment holding company, concentrating on the development and commercialization of endocrine treatments across mainland China, Hong Kong, and Taiwan. Their flagship product, Lonapegsomatropin, offers a once-weekly, long-acting growth hormone replacement designed for pediatric growth hormone deficiency. The company is also progressing other therapies, such as TransCon CNP (navepegritide), a long-acting prodrug utilizing c-type natriuretic peptide for achondroplasia, and Palopegteriparatide, a daily parathyroid hormone replacement therapy intended for chronic hypoparathyroidism. VISEN has forged strategic collaborations with Shanghai Pharmaceutical and United Family Healthcare. The enterprise was founded in 2018 and is based in Suzhou, China.
Show More
CEO
An-bang Lu
Employees
82
Country
China
ISIN
KYG93Y5D1039
WKN
000A413TB
Listings
0 Comments
Share your thoughts
FAQs
What is VISEN Pharmaceuticals stock price today?▼
The current price of VSNPF is $2.10 USD — it has increased by +0% in the past 24 hours. Watch VISEN Pharmaceuticals stock price performance more closely on the chart.
What is VISEN Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange VISEN Pharmaceuticals stocks are traded under the ticker VSNPF.
What is VISEN Pharmaceuticals market cap?▼
Today VISEN Pharmaceuticals has the market capitalization of 239.25M
When is the next VISEN Pharmaceuticals earnings date?▼
VISEN Pharmaceuticals is going to release the next earnings report on April 1, 2027.
What were VISEN Pharmaceuticals earnings last quarter?▼
VSNPF earnings for the last quarter are -0.14 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is VISEN Pharmaceuticals revenue for the last year?▼
VISEN Pharmaceuticals revenue for the last year amounts to 23,584.57 USD.
What is VISEN Pharmaceuticals net income for the last year?▼
VSNPF net income for the last year is -35.83M USD.
How many employees does VISEN Pharmaceuticals have?▼
As of November 8, 2026, the company has 82 employees.
In which sector is VISEN Pharmaceuticals located?▼
VISEN Pharmaceuticals operates in the Health & Wellness sector.
When did VISEN Pharmaceuticals complete a stock split?▼
VISEN Pharmaceuticals has not had any recent stock splits.
Where is VISEN Pharmaceuticals headquartered?▼
VISEN Pharmaceuticals is headquartered in Suzhou, China.